#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA623301	A	Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle	Mus musculus	1	ALA1128343	organism-based format	Scientific Literature
2.	ALA623305	A	Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle	Mus musculus	2	ALA1128343	organism-based format	Scientific Literature
3.	ALA635598	A	Volume of distribution in mice plasma was determined at 40 mg/kg after intravenous administration with 90% DMSO as vehicle	Mus musculus	2	ALA1128343	organism-based format	Scientific Literature
4.	ALA637957	A	Half life in mice plasma was determined at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle	Mus musculus	1	ALA1128343	organism-based format	Scientific Literature
5.	ALA637959	A	Half life in mice plasma was determined at 40 mg/kg after intravenous administration with 90% DMSO as vehicle	Mus musculus	2	ALA1128343	organism-based format	Scientific Literature
6.	ALA816090	B	Inhibition of HSV-1 thymidine kinase, 1 uM [3H]thymidine and ATP as phosphate donor	Human alphaherpesvirus 1	17	ALA1128343	single protein format	Scientific Literature
7.	ALA816091	B	Binding affinity towards HSV-1 thymidine kinase was determined	Human alphaherpesvirus 1	2	ALA1128343	single protein format	Scientific Literature
8.	ALA811287	B	Inhibition of HSV-2 thymidine kinase, 2 uM [3H]thymidine and ATP as phosphate donor	Human alphaherpesvirus 2	17	ALA1128343	single protein format	Scientific Literature
9.	ALA832665	B	Inhibitory concentration against herpes simplex virus type 1 thymidine kinase	herpes simplex virus type 1	29	ALA1139534	single protein format	Scientific Literature
10.	ALA832666	B	Inhibitory concentration against herpes simplex virus type 2 thymidine kinase	Human alphaherpesvirus 2	29	ALA1139534	single protein format	Scientific Literature
11.	ALA874846	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 100 mg/kg; expressed as mean day of death	Mus musculus	5	ALA1139534	organism-based format	Scientific Literature
12.	ALA874847	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 200 mg/kg; expressed as mean day of death	Mus musculus	2	ALA1139534	organism-based format	Scientific Literature
13.	ALA874848	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 400 mg/kg; expressed as mean day of death	Mus musculus	2	ALA1139534	organism-based format	Scientific Literature
14.	ALA874849	F	Effect on HSV-2 encephalitis in mice following intraperitoneal dosage at 100 mg/kg; expressed as mean day of death	Mus musculus	6	ALA1139534	organism-based format	Scientific Literature
15.	ALA874850	F	Effect on HSV-2 encephalitis in mice following intraperitoneal dosage at 200 mg/kg; expressed as mean day of death	Mus musculus	3	ALA1139534	organism-based format	Scientific Literature
16.	ALA835838	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 100 mg/kg; expressed as number of survivors/10	Mus musculus	5	ALA1139534	organism-based format	Scientific Literature
17.	ALA835839	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 200 mg/kg; expressed as number of survivors/10	Mus musculus	2	ALA1139534	organism-based format	Scientific Literature
18.	ALA835840	F	Effect on HSV-1 encephalitis in mice following intraperitoneal dosage at 400 mg/kg; expressed as number of survivors/10	Mus musculus	2	ALA1139534	organism-based format	Scientific Literature
19.	ALA835841	F	Effect on HSV-2 encephalitis in mice following intraperitoneal dosage at 100 mg/kg; expressed as number of survivors/10	Mus musculus	6	ALA1139534	organism-based format	Scientific Literature
20.	ALA835842	F	Effect on HSV-2 encephalitis in mice following intraperitoneal dosage at 200 mg/kg; expressed as number of survivors/10	Mus musculus	3	ALA1139534	organism-based format	Scientific Literature